Diffusion of breast cancer risk assessment in primary care C

Journal of the American Board of Family Medicine

Volumn 22, Issue 2, 2009, Pages 272-279

  Guerra, Carmen E ^a,b   Sherman, Melani ^a   Armstrong, Katrina ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER RISK; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; MEDICAL EDUCATION; MEDICAL INFORMATION; PRIMARY MEDICAL CARE; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; CANCER TEST; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; HEALTH EDUCATION; KNOWLEDGE; PHYSICIAN ATTITUDE; PREVALENCE; RANDOM SAMPLE; RISK ASSESSMENT; RISK FACTOR;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DIFFUSION OF INNOVATION; EARLY DETECTION OF CANCER; FAMILY PRACTICE; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; OBSTETRICS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRIMARY HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT; UNITED STATES;

EID: 67049098994     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2009.03.080153     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda (MD): National Cancer Institute, 2006.
3. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
4. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000;342:564-571 (Pubitemid 30117898)
5. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005;97:1652-1662
6. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 2003;95:526-532 (Pubitemid 36511623)
7. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group [see comment]. J Clin Oncol 2004;22:1055-1062 (Pubitemid 41095038)
8. Gail MH, Costantino JP. Validating and improving models for projecting the absolute risk of breast cancer [comment]. J Natl Cancer Inst 2001;93:334-335 (Pubitemid 32229370)
9. Shattuck-Eidens D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 1997;278:1242-1250
10. Couch F, DeShano M, Blackwood M, Weber B. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997;336:1409-1415 (Pubitemid 27208599)
11. Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16:2417-2425
12. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer 1994;73:643-651
13. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-158 (Pubitemid 28093844)
14. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003;21:593-601. (Pubitemid 46621891)
15. Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties [see comment]. J Clin Oncol 1998;16:3105-3114 (Pubitemid 28417433)
16. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333
17. US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. Ann Intern Med 2005;143:355-361
18. Haas J, Kaplan C, Gregorich S, Perez-Stable E, Des Jarlais G. Do physicians tailor their recommendations for breast cancer risk reduction based on patient risk? J Gen Intern Med 2004;19:302-308
19. Kaplan CP, Haas JS, Perez-Stable EJ, Des Jarlais G, Gregorich SE. Factors affecting breast cancer risk reduction practices among California physicians. Prev Med 2005;41:7-15. (Pubitemid 40755058)
20. Green L, Eriksen M, Schor E. Preventive practices by physicians: behavioral determinants and potential interventions. Am J Prev Med 1988;4:101-107 (Pubitemid 18218060)
21. Green L, Kreuter M. Health promotion planning. 2nd ed. Mountain View: Mayfield Publishing Co; 1991.
22. Armstrong K, Quistberg DA, Micco E, Domchek S, Guerra C. Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med 2006;(166):2260-2265
23. Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 2003;12:295-303.
24. Rogers E. Diffusion of innovations. New York: Free Press; 1995.
25. Greenberg MR. The diffusion of public health innovations. Am J Public Health 2006;96:209-210 (Pubitemid 43167117)
26. Rogers EM. A prospective and retrospective look at the diffusion model. J Health Commun 2004;9(Suppl 1):13-19 (Pubitemid 38367015)
27. Haider M, Kreps GL. Forty years of diffusion of innovations: utility and value in public health. J Health Commun 2004;9(Suppl 1):3-11. (Pubitemid 38367014)
28. Berwick DM. Disseminating innovations in health care. JAMA 2003;289:1969-1975.
29. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50:1129-1136
30. Romm FJ, Hulka BS, Kelly LW Jr. Internists' perceptions and performance in office practice. South Med J 1980;73:405-410 (Pubitemid 12199050)
31. McPhee S, Richard R, Solkowitz S. Performance of cancer screening in a university general internal medicine practice: comparison with the 1980 American Cancer Society Guidelines. J Gen Int Med 1986;1:275-281
32. Wu L, Ashton C. Chart review. A need for reappraisal. Eval Health Prof 1997;20:146-163
33. Nelson H, Huffman L, Fu R, Harris E, Walker M, Bougatsos C. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. Portland: Oregon Evidence-based Practice Center, Oregon Health & Science University; 2005: contract number 290-02-0024.